NCT01390649 - A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Immune Thrombocytopenic Purpura

Interventions

BIOLOGICAL

IgPro10

IgPro10 will be administrated by IV infusion either a single dose of 1 g/kg bw on 1 day or 2 doses of 1 g/kg bw on 2 days (2 g/kg bw total dose) dependent on the response to the first treatment.

Trial Locations (17)

Unknown

"UMHAT Dr. Georgi Stranski Clinic of Haematology", Pleven

"UMHAT Sv. Georgi Clinic of Haematology", Plovdiv

Tokuda Hospital, Sofia

Emergency Clinical County Hospital Baia Mare, Baia Mare

Emergency Clinical County Hospital Brasov, Brasov

"Clinical Institute Fundeni", Bucharest

Universitary Hospital, Bucharest

"Clinical City Hospital Filantropia", Craiova

City Hospital Oradea, Oradea

Emergency Clinical County Hospital Tg. Mures, Tg. Mures

Emergency Clinical City Hospital Timisoara, Timișoara

Oncomed SRL, Timișoara

Salvo-San-Ciobanca SRL, Zalău

Clinical Center of Serbia, Belgrade

Clinical Hospital Bezanijska Kosa, Belgrade

Clinical Hospital Zemun, Belgrade

Clinical Center Nis, Niš